These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 1978434)

  • 1. Principal lymphocyte subpopulation in local host response to human oesophageal cancer.
    Tahara H; Siozaki H; Kobayashi K; Yano H; Tamura S; Miyata M; Wakasa K; Sakurai M; Mori T
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):311-7. PubMed ID: 1978434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic characteristics of tumour-infiltrating lymphocytes in human oesophageal cancer tissues defined by quantitative two-colour analysis with flow-cytometry.
    Tahara H; Shiozaki H; Kobayashi K; Yano T; Yano H; Tamura S; Oku K; Miyata M; Wakasa K; Sakurai M
    Virchows Arch A Pathol Anat Histopathol; 1990; 416(4):329-34. PubMed ID: 2137953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck.
    Hald J; Rasmussen N; Claesson MH
    Cancer Immunol Immunother; 1995 Oct; 41(4):243-50. PubMed ID: 7489567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype.
    Rivoltini L; Arienti F; Orazi A; Cefalo G; Gasparini M; Gambacorti-Passerini C; Fossati-Bellani F; Parmiani G
    Cancer Immunol Immunother; 1992; 34(4):241-51. PubMed ID: 1311218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
    Kowalczyk D; Skorupski W; Kwias Z; Nowak J
    Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
    List AF; Spier CM; Miller TP; Grogan TM
    Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours.
    Schöndorf T; Engel H; Lindemann C; Kolhagen H; von Rücker AA; Mallmann P
    Cancer Immunol Immunother; 1997 Apr; 44(2):88-96. PubMed ID: 9177470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterisation of tumour infiltrating lymphocytes in oral squamous cell carcinoma.
    Stephens M; Lim K; Stephens P; Thomas DW; Lim SH
    Cancer Immunol Immunother; 1998 Mar; 46(1):34-40. PubMed ID: 9520290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma.
    Mizukami Y; Kono K; Daigo Y; Takano A; Tsunoda T; Kawaguchi Y; Nakamura Y; Fujii H
    Cancer Sci; 2008 Jul; 99(7):1448-54. PubMed ID: 18452554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte infiltration in oesophageal carcinoma: lack of correlation with MHC antigens, ICAM-1, and tumour stage and grade.
    Rockett JC; Darnton SJ; Crocker J; Matthews HR; Morris AG
    J Clin Pathol; 1996 Mar; 49(3):264-7. PubMed ID: 8675745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma.
    Facchetti P; Prigione I; Ghiotto F; Tasso P; Garaventa A; Pistoia V
    Cancer Immunol Immunother; 1996 Mar; 42(3):170-8. PubMed ID: 8640845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
    Indrová M; Bieblová J; Rossowska J; Kuropka P; Pajtasz-Piasecka E; Bubeník J; Reinis M
    Int J Oncol; 2009 Jan; 34(1):173-9. PubMed ID: 19082488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites.
    Albers AE; Ferris RL; Kim GG; Chikamatsu K; DeLeo AB; Whiteside TL
    Cancer Immunol Immunother; 2005 Nov; 54(11):1072-81. PubMed ID: 15959774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.